Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (II)-28-1 (IGHVII-28-1) is classified as a pseudogene found in the human immunoglobulin heavy chain locus on chromosome 14[2][4][6][8]. As a pseudogene, it does not encode a functional immunoglobulin heavy chain variable region and therefore does not contribute to antigen recognition or to the formation of antibody molecules. Immunoglobulin heavy variable regions are typically important for the diversity and antigen specificity of antibody molecules produced by B lymphocytes[1][5]. However, IGHVII-28-1 lacks protein-coding capability and is not considered a therapeutic target, nor does it have known roles in human disease, drug interaction, or function as a biomarker[2][4][6][8]. Its main relevance lies in immunogenomics and antibody gene locus organization studies, not in clinical targeting. \n\nKey point: IGHVII-28-1 is a human immunoglobulin heavy variable region pseudogene, not a functional protein or therapeutic target[2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (II)-28-1 (pseudogene) (IGHVII-28-1).